104 related articles for article (PubMed ID: 17956704)
41. Recombinant human granulocyte colony-stimulating factor (rHuG-CSF): effects on lymphocyte phenotype and function.
Rutella S; Rumi C; Sica S; Leone G
J Interferon Cytokine Res; 1999 Sep; 19(9):989-94. PubMed ID: 10505739
[TBL] [Abstract][Full Text] [Related]
42. Hematologic recovery in patients who are treated with autologous stem cells transplantation taken from bone marrow after granulocyte-colony-stimulating factor stimulation.
Gawronski K; Rzepecki P; Oborska S; Wasko-Grabowska A
Transplant Proc; 2011 Oct; 43(8):3114-5. PubMed ID: 21996240
[TBL] [Abstract][Full Text] [Related]
43. T cell-depleted granulocyte colony-stimulating factor (G-CSF) modified allogenic bone marrow transplantation for hematological malignancy improves graft CD34+ cell content but is associated with delayed pancytopenia.
Mavroudis DA; Read EJ; Molldrem J; Raptis A; Plante M; Carter CS; Phang S; Dunbar CE; Barrett AJ
Bone Marrow Transplant; 1998 Mar; 21(5):431-40. PubMed ID: 9535034
[TBL] [Abstract][Full Text] [Related]
44. Acute graft-versus-host disease in a nonhematopoietic stem cell transplantation candidate treated with decitabine followed by granulocyte colony-stimulating factor-primed peripheral blood stem cells infusion: a special entity of the disease?
Yuan L; Sun L; Yang L; Jing Y
Transfusion; 2014 Jan; 54(1):190-3. PubMed ID: 23621702
[TBL] [Abstract][Full Text] [Related]
45. The role of accessory cells in allogeneic peripheral blood stem cell transplantation.
Tanaka J; Imamura M; Kasai M; Asaka M; Torok-Storb B
Int J Hematol; 1999 Feb; 69(2):70-4. PubMed ID: 10071453
[TBL] [Abstract][Full Text] [Related]
46. Long-term engraftment, graft-vs.-host disease, and immunologic reconstitution after experimental transplantation of allogeneic peripheral blood cells from G-CSF-treated donors.
Pan L; Bressler S; Cooke KR; Krenger W; Karandikar M; Ferrara JL
Biol Blood Marrow Transplant; 1996 Oct; 2(3):126-33. PubMed ID: 9199755
[TBL] [Abstract][Full Text] [Related]
47. Cytokine-primed bone marrow stem cells vs. peripheral blood stem cells for autologous transplantation: a randomized comparison of GM-CSF vs. G-CSF.
Weisdorf D; Miller J; Verfaillie C; Burns L; Wagner J; Blazar B; Davies S; Miller W; Hannan P; Steinbuch M; Ramsay N; McGlave P
Biol Blood Marrow Transplant; 1997 Oct; 3(4):217-23. PubMed ID: 9360784
[TBL] [Abstract][Full Text] [Related]
48. G-CSF given after haematopoietic stem cell transplantation using HLA-identical sibling donors is associated to a higher incidence of acute GVHD II-IV.
Remberger M; Naseh N; Aschan J; Barkholt L; LeBlanc K; Svennberg P; Ringdén O
Bone Marrow Transplant; 2003 Jul; 32(2):217-23. PubMed ID: 12838288
[TBL] [Abstract][Full Text] [Related]
49. [The effects of donor peripheral blood stem cell infusion in the prevention of relapse in high risk leukemia after haplotype hematopoietic stem cell transplantation].
Zhang Y; Chen HR; Liu XD; He XP; Lou JX; Guo Z
Zhonghua Nei Ke Za Zhi; 2011 Jun; 50(6):492-5. PubMed ID: 21781534
[TBL] [Abstract][Full Text] [Related]
50. An improved anti-leukemic effect achieved with donor progenitor cell infusion for relapse patients after allogeneic bone marrow transplantation.
Huang X; Guo N; Ren H; Zhang Y; Gao Z; Lu D
Chin Med J (Engl); 2003 May; 116(5):736-41. PubMed ID: 12875692
[TBL] [Abstract][Full Text] [Related]
51. The effect of hematopoietic growth factors on the risk of graft-vs-host disease after allogeneic hematopoietic stem cell transplantation: a meta-analysis.
Ho VT; Mirza NQ; Junco Dd Dd; Okamura T; Przepiorka D
Bone Marrow Transplant; 2003 Oct; 32(8):771-5. PubMed ID: 14520420
[TBL] [Abstract][Full Text] [Related]
52. [Significance of donors treatment with combination of recombinant human interleukin-11 and recombinant human granulocyte-colony stimulating factor in reduction of incidence of lethal grafts versus host disease after allogeneic bone marrow transplantation].
Zhao J; Zhao XY; Huang XJ
Zhonghua Yi Xue Za Zhi; 2005 Sep; 85(35):2497-502. PubMed ID: 16321278
[TBL] [Abstract][Full Text] [Related]
53. Granulocyte colony-stimulating factor affects serum levels of soluble interleukin-2 receptors after allogeneic stem cell transplantation.
Remberger M; Sundberg B
Haematologica; 2005 Mar; 90(3):427-9. PubMed ID: 15749688
[TBL] [Abstract][Full Text] [Related]
54. Granulocyte Colony-Stimulating Factor-Primed Unmanipulated Haploidentical Blood and Marrow Transplantation.
Chang YJ; Zhao XY; Huang XJ
Front Immunol; 2019; 10():2516. PubMed ID: 31749802
[TBL] [Abstract][Full Text] [Related]
55. Granulocyte-colony stimulating factor enhances the expression of transforming growth factor-beta mRNA in CD4-positive peripheral blood lymphocytes in the donors for allogeneic peripheral blood stem cell transplantation.
Hirayama Y; Sakamaki S; Matsunaga T; Kuroda H; Kusakabe T; Akiyama T; Kato J; Kogawa K; Koyama R; Nagai T; Ohta H; Niitsu Y
Am J Hematol; 2002 Feb; 69(2):138-40. PubMed ID: 11835352
[TBL] [Abstract][Full Text] [Related]
56. Granulocyte colony-stimulating factor--primed allogeneic bone marrow transplants: capturing the advantages of blood stem cell transplants without increased risk of chronic graft-versus-host disease.
Donato M; Champlin R
Biol Blood Marrow Transplant; 2000; 6(4A):419-21. PubMed ID: 10975509
[No Abstract] [Full Text] [Related]
57. Immunological heterogeneity of healthy peripheral blood stem cell donors - preharvesting donor characteristics, additional heterogeneity induced by granulocyte colony-stimulating factor and possible importance for outcome after allotransplantation.
Bruserud Ø; Melve GK; Gedde-Dahl T; Tvedt THA
Expert Rev Hematol; 2018 Oct; 11(10):757-759. PubMed ID: 30126308
[No Abstract] [Full Text] [Related]
58. [Progress on research and clinical application of interleukin-11 in treatment of leukemia--review].
Zhang QR
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2004 Oct; 12(5):718-20. PubMed ID: 15498143
[TBL] [Abstract][Full Text] [Related]
59. Successful treatment of partial graft failure after matched unrelated donor stem cell transplantation by a combination of ancestim (stem cell factor) and granulocyte colony stimulating factor in a patient with heavily pre-treated chronic lymphocytic leukemia.
Körper S; Hütter G; Blau W; Blau O; Schrezenmeier H; Knauf W; Thiel E
Leuk Lymphoma; 2008 Oct; 49(10):2015-7. PubMed ID: 18728966
[No Abstract] [Full Text] [Related]
60. Graft-versus-host-disease and granulocyte colony-stimulating factor administration after allogeneic stem cell transplantation.
Mohty M; Faucher C; Blaise D
Leukemia; 2005 Apr; 19(4):500-3. PubMed ID: 15674410
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
